Jaguar Health (JAGX) Preferred Shares (2018 - 2025)

Jaguar Health (JAGX) reported Preferred Shares of $2.5 million for Q4 2025, little changed quarter-over-quarter from $2.5 million in Q3 2025.

Jaguar Health (JAGX) Preferred Shares (2018 - 2025) Analysis & Trends

Jaguar Health (JAGX) has 4 years of Preferred Shares data on file, last reported at $2.5 million in Q4 2025.

Preferred Shares for Q4 2025 came in at $2.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (changed N/A YoY), and the FY2025 annual result was $2.5 million, changed N/A from the prior year.
Preferred Shares was little changed at $2.5 million in Q4 2025 per JAGX's latest filing, from $2.5 million in the prior quarter.
Over five years, Preferred Shares peaked at $2.5 million in Q2 2025 and troughed at $2.5 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	-
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	Jaguar Health	1.44 Mn	-10.19 Mn	19.11 Mn	-

Download Data